Apimeds Pharmaceuticals US, Inc. APUS
2.69 USD -0.02 (-0.74%)
Nov 9, 2026, 11:42 AM EST
2.66 Day range 2.74
1.51 52-week range 59.70
- YTD
- -83.63%
- 1 year
- -87.96%
- Market cap
- 4.05M
- EPS (ttm)
- -36.03
- YTD return
- -83.63%
- 1-year return
- -87.96%
- Volume
- 23.46K
- Avg volume
- 3.76M
- Open
- 2.68
- Previous close
- 2.71
- Day's range
- 2.66 – 2.74
- 52-week range
- 1.51 – 59.70
5D -0.32 (-10.60%)
Financials — quick view
APUS Revenue — quarterly 0
APUS Net income — quarterly -20.17M
APUS EPS — quarterly -11.77
News
Apimeds’ Subsidiary MindWave Innovations Enters Into Shareholders’ And JV Agreement With Skalup Capital To Establish Insurance And Technology Business In Bermuda Under Working Brand Monaco Insurance 
IBN Announces CryptoCurrencyWire Audio Production Featuring Dr. Vin Menon, CEO of MindWave Innovations Inc. 
Apimeds Pharmaceuticals US' Subsidiary Mindwave Innovations Signs Three Agreements Between Sept. 24 And Oct. 4, 2026, To Build And Operate Dedicated Blockchain Networks For Clients In Climate Finance, Sports Media And Insurance 
12 Health Care Stocks Moving In Friday's Intraday Session 
12 Health Care Stocks Moving In Wednesday's Intraday Session - 12 Health Care Stocks Moving In Tuesday's Intraday Session
- 12 Health Care Stocks Moving In Monday's Intraday Session
Why Is Apimeds Pharmaceuticals Stock Gaining Monday? - 12 Health Care Stocks Moving In Monday's Pre-Market Session
Apimeds’ Subsidiary MindWave Signs 12-Month Software Development And Technology Services Agreement With Flash Sports & Media To Build And Operate FlashChain
Your note
Sign in to keep a note on APUS — it syncs with the Stock Master app.